These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15899613)

  • 1. [Breast carcinoma and genomic technology: contribution of DNA microarrays].
    Sévenet N; Cottu PH
    Bull Cancer; 2004 Dec; 91 Suppl 4():S226-31. PubMed ID: 15899613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic signatures in breast cancer.
    Fu J; Jeffrey SS
    Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Agency for Research on Cancer workshop on 'Expression array analyses in breast cancer taxonomy'.
    Tavtigian SV; Pierotti MA; Børresen-Dale AL
    Breast Cancer Res; 2006; 8(6):303. PubMed ID: 17096863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic analysis: toward a new approach in breast cancer management.
    Cavallaro S; Paratore S; de Snoo F; Salomone E; Villari L; Buscarino C; Ferraù F; Banna G; Furci M; Strazzanti A; Cunsolo R; Pezzino S; Gangi S; Basile F
    Crit Rev Oncol Hematol; 2012 Mar; 81(3):207-23. PubMed ID: 21511492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
    Weigelt B; Kreike B; Reis-Filho JS
    Breast Cancer Res Treat; 2009 Sep; 117(2):273-80. PubMed ID: 18815879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular classification of breast cancer: limitations and potential.
    Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
    Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited tissue fixation times and whole genomic amplification do not impact array CGH profiles.
    Ghazani AA; Arneson NC; Warren K; Done SJ
    J Clin Pathol; 2006 Mar; 59(3):311-5. PubMed ID: 16505285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH.
    Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM
    Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of breast cell lines identifies potential new basal markers.
    Charafe-Jauffret E; Ginestier C; Monville F; Finetti P; Adélaïde J; Cervera N; Fekairi S; Xerri L; Jacquemier J; Birnbaum D; Bertucci F
    Oncogene; 2006 Apr; 25(15):2273-84. PubMed ID: 16288205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer special types: why bother?
    Reis-Filho JS; Lakhani SR
    J Pathol; 2008 Dec; 216(4):394-8. PubMed ID: 18798222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New molecular classifications of breast cancer.
    Cianfrocca M; Gradishar W
    CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
    Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
    Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput genomic technology in research and clinical management of breast cancer. Evolving landscape of genetic epidemiological studies.
    Low YL; Wedrén S; Liu J
    Breast Cancer Res; 2006; 8(3):209. PubMed ID: 16834767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
    Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.
    Tan DS; Reis-Filho JS
    Pathobiology; 2008; 75(2):63-74. PubMed ID: 18544961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.